Main concept: Isotretinoin has major safety risks that require ongoing monitoring. This drug is highly teratogenic, so pregnancy must be prevented and frequent pregnancy testing and contraception are required during treatment. In addition, it can cause hepatotoxicity and lipid abnormalities, so liver function tests and lipid panels are monitored regularly. Because of these significant safety concerns, the idea that it’s just a desired effect or that it has no safety concerns is incorrect, and safety issues are present with systemic use (not just topical). The option describing it as a potential adverse effect requiring monitoring best captures why monitoring is essential.

In electrosurgical cutting, controlling how long the electrode stays in contact with tissue is crucial to limit heat spread and tissue damage. The cutting electrode should be applied only briefly so the tissue is incised cleanly without excessive thermal injury to surrounding structures. About five seconds is the maximum recommended exposure for a single incision. Keeping it to this short time helps prevent carbonization and deep thermal damage, which can impair healing and obscure the incision margins. If more length is needed, you stop, lift, and reposition for additional passes rather than sustaining contact longer than necessary. Longer contact can cause charring, wider zones of necrosis, and poorer wound healing, which is why a five-second limit is preferred.

Sodium channel blockade in cardiac tissue is what drives cardiovascular toxicity from local anesthetics. These drugs bind to voltage-gated sodium channels and stabilize them in the inactivated state, preventing sodium influx during the rapid depolarization (phase 0). In the heart, this slows conduction across the myocardium and through the His-Purkinje system, leading to slower atrioventricular conduction, QRS widening, bradycardia, and, in severe cases, heart block or asystole. This is the same basic mechanism by which local anesthetics block nerve impulses, but at toxic levels the effect extends to the heart. While very high concentrations can have other effects, the clinically relevant cardiovascular toxicity stems primarily from Na+ channel blockade.

Amide local anesthetics are inactivated mainly by the liver. They are metabolized by hepatic enzymes—primarily amidases and parts of the cytochrome P450 system—into inactive metabolites, with the kidneys responsible for excreting those metabolites. The lungs and spleen don’t play a significant role in their metabolism, and this is in contrast to ester local anesthetics, which are rapidly hydrolyzed by plasma cholinesterases. Clinically, impaired liver function slows this metabolism, prolonging effects and raising toxicity risk, which reinforces why the liver is the primary organ involved.